Literature DB >> 12649496

Antagonistic regulation of alpha-actinin alternative splicing by CELF proteins and polypyrimidine tract binding protein.

Natalia Gromak1, Arianne J Matlin, Thomas A Cooper, Christopher W J Smith.   

Abstract

The alpha-actinin gene has a pair of alternatively spliced exons. The smooth muscle (SM) exon is repressed in most cell types by polypyrimidine tract binding protein (PTB). CELF (CUG-BP and ETR3-like factors) family proteins, splicing regulators whose activities are altered in myotonic dystrophy, were found to coordinately regulate selection of the two alpha-actinin exons. CUG-BP and ETR3 activated the SM exon, and along with CELF4 they were also able to repress splicing of the NM (nonmuscle) exon both in vivo and in vitro. Activation of SM exon splicing was associated with displacement of PTB from the polypyrimidine tract by binding of CUG-BP at adjacent sites. Our data provides direct evidence for the activity of CELF proteins as both activators and repressors of splicing within a single-model system of alternative splicing, and suggests a model whereby alpha-actinin alternative splicing is regulated by synergistic and antagonistic interactions between members of the CELF and PTB families.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12649496      PMCID: PMC1370411          DOI: 10.1261/rna.2191903

Source DB:  PubMed          Journal:  RNA        ISSN: 1355-8382            Impact factor:   4.942


  53 in total

Review 1.  Alternative splicing: combinatorial output from the genome.

Authors:  Gavin C Roberts; Christopher W J Smith
Journal:  Curr Opin Chem Biol       Date:  2002-06       Impact factor: 8.822

Review 2.  Listening to silence and understanding nonsense: exonic mutations that affect splicing.

Authors:  Luca Cartegni; Shern L Chew; Adrian R Krainer
Journal:  Nat Rev Genet       Date:  2002-04       Impact factor: 53.242

3.  Aberrant regulation of insulin receptor alternative splicing is associated with insulin resistance in myotonic dystrophy.

Authors:  R S Savkur; A V Philips; T A Cooper
Journal:  Nat Genet       Date:  2001-09       Impact factor: 38.330

4.  Exon identity established through differential antagonism between exonic splicing silencer-bound hnRNP A1 and enhancer-bound SR proteins.

Authors:  J Zhu; A Mayeda; A R Krainer
Journal:  Mol Cell       Date:  2001-12       Impact factor: 17.970

5.  Region-specific alternative splicing in the nervous system: implications for regulation by the RNA-binding protein NAPOR.

Authors:  Wenqing Zhang; Haiying Liu; Kyoungha Han; Paula J Grabowski
Journal:  RNA       Date:  2002-05       Impact factor: 4.942

6.  Dynamic antagonism between ETR-3 and PTB regulates cell type-specific alternative splicing.

Authors:  Nicolas Charlet-B; Penny Logan; Gopal Singh; Thomas A Cooper
Journal:  Mol Cell       Date:  2002-03       Impact factor: 17.970

7.  Regulation of alternative splicing of alpha-actinin transcript by Bruno-like proteins.

Authors:  Hitoshi Suzuki; Yui Jin; Hifumi Otani; Kunio Yasuda; Kunio Inoue
Journal:  Genes Cells       Date:  2002-02       Impact factor: 1.891

8.  Cardiac elav-type RNA-binding protein (ETR-3) binds to RNA CUG repeats expanded in myotonic dystrophy.

Authors:  X Lu; N A Timchenko; L T Timchenko
Journal:  Hum Mol Genet       Date:  1999-01       Impact factor: 6.150

9.  Brain-specific splicing of alpha-actinin 1 (ACTN1) mRNA.

Authors:  Joachim Kremerskothen; Iskender Teber; Doreen Wendholt; Thomas Liedtke; Tobias M Böckers; Angelika Barnekow
Journal:  Biochem Biophys Res Commun       Date:  2002-07-19       Impact factor: 3.575

Review 10.  Alternative splicing: multiple control mechanisms and involvement in human disease.

Authors:  Javier F Cáceres; Alberto R Kornblihtt
Journal:  Trends Genet       Date:  2002-04       Impact factor: 11.639

View more
  45 in total

Review 1.  Diverse regulation of 3' splice site usage.

Authors:  Muhammad Sohail; Jiuyong Xie
Journal:  Cell Mol Life Sci       Date:  2015-09-14       Impact factor: 9.261

2.  Characterization of multimeric complexes formed by the human PTB1 protein on RNA.

Authors:  Caroline Clerte; Kathleen B Hall
Journal:  RNA       Date:  2006-01-23       Impact factor: 4.942

3.  STAR family RNA-binding protein ASD-2 regulates developmental switching of mutually exclusive alternative splicing in vivo.

Authors:  Genta Ohno; Masatoshi Hagiwara; Hidehito Kuroyanagi
Journal:  Genes Dev       Date:  2008-01-29       Impact factor: 11.361

4.  Polypyrimidine tract binding protein prevents activity of an intronic regulatory element that promotes usage of a composite 3'-terminal exon.

Authors:  Vincent Anquetil; Caroline Le Sommer; Agnès Méreau; Sandra Hamon; Hubert Lerivray; Serge Hardy
Journal:  J Biol Chem       Date:  2009-09-17       Impact factor: 5.157

5.  CUG-BP1/CELF1 requires UGU-rich sequences for high-affinity binding.

Authors:  Julien Marquis; Luc Paillard; Yann Audic; Bertrand Cosson; Olivier Danos; Christine Le Bec; H Beverley Osborne
Journal:  Biochem J       Date:  2006-12-01       Impact factor: 3.857

6.  Polypyrimidine tract binding protein blocks the 5' splice site-dependent assembly of U2AF and the prespliceosomal E complex.

Authors:  Shalini Sharma; Arnold M Falick; Douglas L Black
Journal:  Mol Cell       Date:  2005-08-19       Impact factor: 17.970

Review 7.  Misregulation of alternative splicing causes pathogenesis in myotonic dystrophy.

Authors:  N Muge Kuyumcu-Martinez; Thomas A Cooper
Journal:  Prog Mol Subcell Biol       Date:  2006

8.  Quaking and PTB control overlapping splicing regulatory networks during muscle cell differentiation.

Authors:  Megan P Hall; Roland J Nagel; W Samuel Fagg; Lily Shiue; Melissa S Cline; Rhonda J Perriman; John Paul Donohue; Manuel Ares
Journal:  RNA       Date:  2013-03-22       Impact factor: 4.942

9.  ETR-3 and CELF4 protein domains required for RNA binding and splicing activity in vivo.

Authors:  Gopal Singh; Nicolas Charlet-B; Jin Han; Thomas A Cooper
Journal:  Nucleic Acids Res       Date:  2004-02-18       Impact factor: 16.971

10.  SRp20 and CUG-BP1 modulate insulin receptor exon 11 alternative splicing.

Authors:  Supriya Sen; Indrani Talukdar; Nicholas J G Webster
Journal:  Mol Cell Biol       Date:  2008-12-01       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.